Company Monitoring Page for Shire

latest headlines for company on cafepharma

Shire buys Advanced BioHealing for $750M
FierceMedicalDevice
Wed, 05/18/11 - 06:33 pm
Tags:
Shire, Advanced BioHealing, buyouts
Shire swoops to buy Advanced BioHealing
Pharma Times, UK
Wed, 05/18/11 - 11:23 am
Tags:
Advanced BioHealing, Shire, M&A, diabetic foot ulcers, regenerative medicine
Shire eyes huge sales from new Vyvanse uses
Reuters
Thu, 05/12/11 - 11:52 am
Tags:
Vyvanse, Shire, schizophrenia, depression, ADHD
Revenues Rise at Shire
Yahoo/Zacks.com
Tue, 05/3/11 - 07:05 am
Tags:
earnings, Shire
Shire, Watson in Legal Battle
Yahoo/Zacks.com
Thu, 04/7/11 - 05:14 pm
Tags:
Watson Pharmaceuticals, Shire, Adderall XR, patents
Protalix Plans Human Clinical Tests of Medication for Rare Fabry's Disease
Bloomberg
Thu, 03/24/11 - 03:00 pm
Tags:
Protalix BioTherapeutics, Fabry's disease, rheumatoid arthritis, PRX-102, Genzyme, Fabrazyme, Shire, Replagal
Shire advances rival to Dyax drug
Bizjournals.com
Mon, 03/21/11 - 11:34 am
Tags:
Shire, Dyax, hereditary angiodema, Kalbitor, Firazyr
Niche Opportunity May Be Slipping From Protalix's Grasp
Seeking Alpha
Tue, 03/1/11 - 10:31 am
Tags:
Protalix BioTherapeutics, UPLYSO, Gaucher disease, Shire, Cerezyme, Genzyme, Vpriv
Shire wins FDA approval for ADHD drug
Bizjournals.com
Mon, 02/28/11 - 01:37 pm
Tags:
FDA, Shire, ADHD, Intuniv
Shire Stock Hits New 52-Week High (SHPGY)
The Street
Sat, 02/26/11 - 10:30 am
Tags:
Shire
Pfizer, Protalix Fail to Win FDA Approval of Cerezyme Rival
Bloomberg
Fri, 02/25/11 - 08:41 am
Tags:
FDA, Protalix BioTherapeutics, Pfizer, Cerezyme, taliglucerase alfa, Shire, Genzyme
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
Tags:
M&A, biotech, Biogen Idec, Human Genome, Seattle Genetics, GSK, Dendreon, Actelion, Biomarin, Exelixis, Vertex Pharmaceuticals, Celgene, Alexion, Shire, InterMune, Lexicon Pharmaceuticals, Savient, Merck KGaA
The Next Big Pharma Share?
Motley Fool
Fri, 02/11/11 - 07:44 am
Tags:
GSK, Shire, AstraZeneca
Pfizer, Shire, Novartis Alzheimer’s Drugs Win U.K. NICE Backing
Bloomberg
Tue, 01/18/11 - 07:55 am
Tags:
UK, NICE, Pfizer, Novartis, Shire, Alzheimer's disease
Shire Adds Patients, Capacity for Replagal, Vpriv
Bloomberg
Thu, 01/13/11 - 01:20 pm
Tags:
Replagal, Vpriv, Shire
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:24 pm
Tags:
Watson Pharmaceuticals, Theratechnologies, Shire, Savient, Sanofi, Roche, Orphan Europe, Novo Nordisk, Novartis, Merz, JNJ, HRA Pharma, Genzyme, Forest Labs, FDA, Eisai, Dainippon Sumitomo, Chemiche Fabrik Kresussler, Boehringer Ingelheim, Bayer, Auxilium, Amgen, Allergan, Acorda Therapeutics
Rare diseases: All the rage in Big Pharma
Fierce Pharma
Thu, 11/18/10 - 08:17 am
Tags:
Big Pharma, GSK, Shire, Genzyme, Amicus Therapeutics, Hyperion Therapeutics, CMC Biologics, Edimer
Shire Profit Rises on Vyvanse Sales, Genzyme Delays
Bloomberg
Fri, 10/29/10 - 12:05 pm
Tags:
Shire, earnings
10 Pharmaceutical Stocks With Up to 88% Upside
TheStreet.com
Tue, 10/12/10 - 11:01 am
Tags:
Novartis, Allergan, Shire, AstraZeneca, Abbott Laboratories, Merck, Pfizer, Teva Pharmaceuticals, Warner Chilcott, Valeant Pharmaceuticals
Acceleron inks $498M pact with Shire for lead muscle drug
Fierce Biotech
Thu, 09/9/10 - 12:30 pm
Tags:
Shire, Acceleron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.